Corneal Transplant Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), Corneal Graft, Corneal Limbal Stem Cell Transplant, Others), By Indication (Fungal Corneal Ulcer, Bullous Keratopathy, Keratoconus, Keratitis, Corneal Stromal Dystrophies, Others), By End User (Hospitals, Eye Clinics, Others), and Region Forecast 2019-2030

Corneal Transplant Market size was valued at US$ 465.8  million in 2023 and is expected to grow at 8.2% CAGR from 2024-2030. Corneal transplant refers to the surgical procedure of replacing a damaged or diseased cornea with a healthy one from a donor. The procedure is commonly known as keratoplasty and is essential for restoring vision in individuals suffering from various corneal diseases and conditions. The market encompasses medical devices, surgical equipment, pharmaceuticals, and other products and services that cater to the growing demand for corneal transplant procedures worldwide.

According to data from reputable sources such as the World Health Organization (WHO) and the American Academy of Ophthalmology (AAO), corneal diseases are a significant cause of visual impairment and blindness globally. It is estimated that approximately 12.7 million people worldwide suffer from bilateral corneal blindness, with cataracts and glaucoma being the leading causes of unilateral corneal blindness. The prevalence of corneal diseases is particularly high in developing countries due to various factors, including limited access to quality eye care services and a higher incidence of infectious eye diseases. Moreover, corneal diseases and injuries can result from various causes, such as trauma, infections, hereditary conditions, and degenerative disorders. Among the most prevalent indications for corneal transplants are keratoconus, Fuchs' endothelial dystrophy, corneal scarring from injuries or infections, and corneal edema. These conditions can lead to severe visual impairment or complete loss of vision, significantly impacting the quality of life for affected individuals. The demand for corneal transplants is expected to increase with the aging global population and the rising prevalence of eye diseases. Technological advancements, including minimally invasive surgical techniques and improved tissue preservation methods, are further driving the growth of the market. Governments and healthcare organizations worldwide are emphasizing the need for increased awareness, early diagnosis, and improved accessibility to corneal transplant procedures, ultimately contributing to better visual outcomes and reducing the burden of corneal diseases on society.

Key Developments

• In January 2022, Alcon the leader in eye care dedicated to assisting people in seeing brilliantly, declared the closing of its formerly announced acquisition of Ivantis, creator of the novel Hydrus microstent, a minimally invasive glaucoma surgery (MIGS) instrument created to lower eye pressure for open-angle glaucoma patients in association with cataract surgery.